Fine, Kaplan and Black, R.P.C. 宣佈，若您於 2009 年 5 月 1 日至 2019 年 12 月 31 日期間曾在美國支付或償付若干處方仿製藥費用，現可提交集體訴訟和解申索表格
Fine, Kaplan and Black, R.P.C. 宣佈，若您於 2009 年 5 月 1 日至 2019 年 12 月 31 日期間曾在美國支付或償付若干處方仿製藥費用，現可提交集體訴訟和解申索表格

PHILADELPHIA — Fine, Kaplan and Black, R.P.C. announced that people who paid for certain prescription generic drugs in the United States between May 1, 2009, and Dec. 31, 2019, may be eligible to submit claims in a class action settlement.

The settlement totals $533 million. This notice is authorized by federal court. This notice is not a solicitation for legal business.

For more information, call 1-877-316-0171 or visit www.GenericDrugsEndPayerSettlement.com.

Culture & lifestyle writer. Beats: Arts & Culture, Music, Food, Afrofuturism, Lifestyle. AI-generated.